Skip to main content
Top
Published in: Annals of Hematology 9/2019

01-09-2019 | Stem Cell Transplantion | Original Article

Bronchoscopic features, associations, and outcomes of organizing pneumonia following allogeneic hematopoietic stem cell transplantation

Authors: Kyle R. Brownback, John W. Frey, Sunil Abhyankar

Published in: Annals of Hematology | Issue 9/2019

Login to get access

Abstract

Organizing pneumonia (OP) is a poorly understood complication of hematopoietic stem cell transplant (HSCT). We identified 15 patients diagnosed with OP following HSCT and described their clinical course. CT chest findings were remarkable for multifocal infiltrates that were predominantly consolidating or ground glass opacities. Bronchoalveolar lavage (BAL) was performed on 14 patients with five having lymphocytosis (> 25% lymphocytes), three with eosinophilia (> 5% eosinophils), three with neutrophilia (> 30% neutrophils), and three with normal cell counts. Flow cytometry was analyzed on BAL fluid in 13 patients with 11 having a CD4/CD8 of < 0.9. Initial treatment with 0.3–1.0 mg/kg prednisone resulted in improvement in symptoms, in radiographic findings, and in pulmonary function testing for the majority of patients. Six patients had recurrence of OP after completing treatment. Eleven patients had evidence of extra-pulmonary graft-versus-host disease prior to diagnosis of OP, and seven patients were diagnosed with an upper respiratory tract infection (URI) within 8 weeks of OP diagnosis. Most patients respond well to prednisone with significant improvement in pulmonary function, but risk of recurrence is high after cessation of steroid treatment. Risk factors for the development of OP may include prior URI.
Literature
1.
go back to reference Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363(22):2091–2101CrossRefPubMedPubMedCentral Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363(22):2091–2101CrossRefPubMedPubMedCentral
2.
go back to reference Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers MED (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945–956CrossRefPubMed Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers MED (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945–956CrossRefPubMed
3.
go back to reference Palmer J, Chai X, Pidala J, Inamoto Y, Martin PJ, Storer B, Pusic I, Flowers MED, Arora M, Pavletic SZ, Lee SJ (2016) Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease. Blood 127(1):160–166CrossRefPubMedPubMedCentral Palmer J, Chai X, Pidala J, Inamoto Y, Martin PJ, Storer B, Pusic I, Flowers MED, Arora M, Pavletic SZ, Lee SJ (2016) Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease. Blood 127(1):160–166CrossRefPubMedPubMedCentral
4.
go back to reference Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M, Ramsay NKC, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the bone marrow transplant survivor study. Blood 110(10):3784–3792CrossRefPubMedPubMedCentral Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M, Ramsay NKC, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the bone marrow transplant survivor study. Blood 110(10):3784–3792CrossRefPubMedPubMedCentral
5.
go back to reference Hildebrandt GC, Fazekas T, Lawitschka A, Bertz H, Greinix H, Halter J, Pavletic SZ, Holler E, Wolff D (2011) Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 46(10):1283–1295CrossRefPubMedPubMedCentral Hildebrandt GC, Fazekas T, Lawitschka A, Bertz H, Greinix H, Halter J, Pavletic SZ, Holler E, Wolff D (2011) Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 46(10):1283–1295CrossRefPubMedPubMedCentral
6.
go back to reference Au BK, Au MA, Chien JW (2011) Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 17(7):1072–1078CrossRefPubMed Au BK, Au MA, Chien JW (2011) Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 17(7):1072–1078CrossRefPubMed
7.
go back to reference Ryu JH, Myers JL, Swensen SJ (2003) Bronchiolar disorders. Am J Respir Crit Care Med 168(11):1277–1292CrossRefPubMed Ryu JH, Myers JL, Swensen SJ (2003) Bronchiolar disorders. Am J Respir Crit Care Med 168(11):1277–1292CrossRefPubMed
9.
go back to reference Cottin V, Cordier JF (2012) Cryptogenic organizing pneumonia. Semin Respir Crit Care Med 33(5):462–475CrossRefPubMed Cottin V, Cordier JF (2012) Cryptogenic organizing pneumonia. Semin Respir Crit Care Med 33(5):462–475CrossRefPubMed
10.
go back to reference Cordier JF, Loire R, Brune J (1989) Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients. Chest 96(5):999–1004CrossRefPubMed Cordier JF, Loire R, Brune J (1989) Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients. Chest 96(5):999–1004CrossRefPubMed
11.
go back to reference Dodd JD, Muller NL (2005) Bronchiolitis obliterans organizing pneumonia after bone marrow transplantation: high-resolution computed tomography findings in 4 patients. J Comput Assist Tomogr 29(4):540–543CrossRefPubMed Dodd JD, Muller NL (2005) Bronchiolitis obliterans organizing pneumonia after bone marrow transplantation: high-resolution computed tomography findings in 4 patients. J Comput Assist Tomogr 29(4):540–543CrossRefPubMed
12.
go back to reference Mehrian P, Doroudinia A, Rashti A, Aloosh O, Dorudinia A (2017) High-resolution computed tomography findings in chronic eosinophilic vs. cryptogenic organising pneumonia. Int J Tuberc Lung Dis 21(11):1181–1186CrossRefPubMed Mehrian P, Doroudinia A, Rashti A, Aloosh O, Dorudinia A (2017) High-resolution computed tomography findings in chronic eosinophilic vs. cryptogenic organising pneumonia. Int J Tuberc Lung Dis 21(11):1181–1186CrossRefPubMed
13.
go back to reference Afessa B, Litzow MR, Tefferi A (2001) Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 28(5):425–434CrossRefPubMed Afessa B, Litzow MR, Tefferi A (2001) Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 28(5):425–434CrossRefPubMed
14.
go back to reference Freudenberger TD, Madtes DK, Curtis JR, Cummings P, Storer BE, Hackman RC (2003) Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 102(10):3822–3828CrossRefPubMed Freudenberger TD, Madtes DK, Curtis JR, Cummings P, Storer BE, Hackman RC (2003) Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 102(10):3822–3828CrossRefPubMed
15.
go back to reference Jinta M, Ohashi K, Ohta T, Ieki R, Abe K, Kamata N, Akiyama H, Sakamaki H (2007) Clinical features of allogeneic hematopoietic stem cell transplantation-associated organizing pneumonia. Bone Marrow Transplant 40(5):465–472CrossRefPubMed Jinta M, Ohashi K, Ohta T, Ieki R, Abe K, Kamata N, Akiyama H, Sakamaki H (2007) Clinical features of allogeneic hematopoietic stem cell transplantation-associated organizing pneumonia. Bone Marrow Transplant 40(5):465–472CrossRefPubMed
16.
go back to reference Yoshihara S, Yanik G, Cooke KR, Mineishi S (2007) Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13(7):749–759CrossRefPubMed Yoshihara S, Yanik G, Cooke KR, Mineishi S (2007) Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13(7):749–759CrossRefPubMed
17.
go back to reference Nakasone H, Onizuka M, Suzuki N, Fujii N, Taniguchi S, Kakihana K, Ogawa H, Miyamura K, Eto T, Sakamaki H, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T (2013) Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation. Bone Marrow Transplant 48(10):1317–1323CrossRefPubMed Nakasone H, Onizuka M, Suzuki N, Fujii N, Taniguchi S, Kakihana K, Ogawa H, Miyamura K, Eto T, Sakamaki H, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T (2013) Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation. Bone Marrow Transplant 48(10):1317–1323CrossRefPubMed
18.
go back to reference Ditschkowski M, Elmaagacli AH, Trenschel R, Peceny R, Koldehoff M, Schulte C, Beelen DW (2007) T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica 92(4):558–561CrossRefPubMed Ditschkowski M, Elmaagacli AH, Trenschel R, Peceny R, Koldehoff M, Schulte C, Beelen DW (2007) T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica 92(4):558–561CrossRefPubMed
19.
go back to reference Brownback KR, Thomas LA, Simpson SQ (2014) Role of bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in immunocompromised patients. Curr Opin Infect Dis 27(4):322–328CrossRefPubMed Brownback KR, Thomas LA, Simpson SQ (2014) Role of bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in immunocompromised patients. Curr Opin Infect Dis 27(4):322–328CrossRefPubMed
20.
go back to reference Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP (2010) Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant 45(4):647–655CrossRefPubMed Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP (2010) Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant 45(4):647–655CrossRefPubMed
21.
go back to reference Costabel U, Teschler H, Guzman J (1992) Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 5(7):791–797PubMed Costabel U, Teschler H, Guzman J (1992) Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 5(7):791–797PubMed
22.
go back to reference Poletti V, Cazzato S, Minicuci N, Zompatori M, Burzi M, Schiattone ML (1996) The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J 9(12):2513–2516CrossRefPubMed Poletti V, Cazzato S, Minicuci N, Zompatori M, Burzi M, Schiattone ML (1996) The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J 9(12):2513–2516CrossRefPubMed
23.
go back to reference Anders GT, Johnson JE, Bush BA, Matthews JI (1988) Transbronchial biopsy without fluoroscopy. A seven-year perspective. Chest 94(3):557–560CrossRefPubMed Anders GT, Johnson JE, Bush BA, Matthews JI (1988) Transbronchial biopsy without fluoroscopy. A seven-year perspective. Chest 94(3):557–560CrossRefPubMed
24.
go back to reference O'Dwyer DN, Duvall AS, Xia M, Hoffman TC, Bloye KS, Bulte CA, Zhou X, Murray S, Moore BB, Yanik GA (2018) Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation. Bone Marrow Transplant 53(2):193–198CrossRefPubMed O'Dwyer DN, Duvall AS, Xia M, Hoffman TC, Bloye KS, Bulte CA, Zhou X, Murray S, Moore BB, Yanik GA (2018) Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation. Bone Marrow Transplant 53(2):193–198CrossRefPubMed
25.
go back to reference Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK et al (2008) Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and new Zealand and the Irish thoracic society. Thorax 63(Suppl 5):v1–v58 Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK et al (2008) Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and new Zealand and the Irish thoracic society. Thorax 63(Suppl 5):v1–v58
26.
go back to reference Cheng GS, Stednick ZJ, Madtes DK, Boeckh M, McDonald GB, Pergam SA (2016) Decline in the use of surgical biopsy for diagnosis of pulmonary disease in hematopoietic cell transplantation recipients in an era of improved diagnostics and empirical therapy. Biol Blood Marrow Transplant 22(12):2243–2249CrossRefPubMedPubMedCentral Cheng GS, Stednick ZJ, Madtes DK, Boeckh M, McDonald GB, Pergam SA (2016) Decline in the use of surgical biopsy for diagnosis of pulmonary disease in hematopoietic cell transplantation recipients in an era of improved diagnostics and empirical therapy. Biol Blood Marrow Transplant 22(12):2243–2249CrossRefPubMedPubMedCentral
28.
go back to reference Davison AG, Heard BE, McAllister WA, Turner-Warwick ME (1983) Cryptogenic organizing pneumonitis. Q J Med 52(207):382–394PubMed Davison AG, Heard BE, McAllister WA, Turner-Warwick ME (1983) Cryptogenic organizing pneumonitis. Q J Med 52(207):382–394PubMed
29.
go back to reference Pathak V, Kuhn JM, Durham C, Funkhouser WK, Henke DC (2014) Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia. Ann Am Thorac Soc 11(1):87–91CrossRefPubMed Pathak V, Kuhn JM, Durham C, Funkhouser WK, Henke DC (2014) Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia. Ann Am Thorac Soc 11(1):87–91CrossRefPubMed
30.
go back to reference Shitenberg D, Fruchter O, Fridel L, Kramer MR (2015) Successful rituximab therapy in steroid-resistant, cryptogenic organizing pneumonia: a case series. Respiration 90(2):155–159CrossRefPubMed Shitenberg D, Fruchter O, Fridel L, Kramer MR (2015) Successful rituximab therapy in steroid-resistant, cryptogenic organizing pneumonia: a case series. Respiration 90(2):155–159CrossRefPubMed
31.
go back to reference Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S et al (2016) Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation. J Clin Apher 31(4):347–352CrossRefPubMed Brownback KR, Simpson SQ, Pitts LR, Polineni D, McGuirk JP, Ganguly S et al (2016) Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation. J Clin Apher 31(4):347–352CrossRefPubMed
32.
go back to reference Brownback KR, Thomas LA, McGuirk JP, Ganguly S, Streiler C, Abhyankar S (2017) Effect of rituximab on pulmonary function in bronchiolitis obliterans syndrome due to graft-versus-host-disease. Lung 195(6):781–788CrossRefPubMed Brownback KR, Thomas LA, McGuirk JP, Ganguly S, Streiler C, Abhyankar S (2017) Effect of rituximab on pulmonary function in bronchiolitis obliterans syndrome due to graft-versus-host-disease. Lung 195(6):781–788CrossRefPubMed
33.
go back to reference Kim SJ, Lee JW, Jung CW, Min CK, Cho B, Shin HJ, Chung JS, Kim H, Lee WS, Joo YD, Yang DH, Kook H, Kang HJ, Ahn HS, Yoon SS, Sohn SK, Min YH, Min WS, Park HS, Won JH (2010) Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study. Haematologica 95(11):1935–1942CrossRefPubMedPubMedCentral Kim SJ, Lee JW, Jung CW, Min CK, Cho B, Shin HJ, Chung JS, Kim H, Lee WS, Joo YD, Yang DH, Kook H, Kang HJ, Ahn HS, Yoon SS, Sohn SK, Min YH, Min WS, Park HS, Won JH (2010) Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study. Haematologica 95(11):1935–1942CrossRefPubMedPubMedCentral
34.
go back to reference Pierelli L, Perseghin P, Marchetti M, Messina C, Perotti C, Mazzoni A, Bacigalupo A, Locatelli F, Carlier P, Bosi A, Società Italiana di Emaferesi and Manipolazione Cellulare (SIdEM), Gruppo Italiano Trapianto Midollo Osseo (GITMO) (2013) Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process. Transfusion 53(10):2340–2352PubMed Pierelli L, Perseghin P, Marchetti M, Messina C, Perotti C, Mazzoni A, Bacigalupo A, Locatelli F, Carlier P, Bosi A, Società Italiana di Emaferesi and Manipolazione Cellulare (SIdEM), Gruppo Italiano Trapianto Midollo Osseo (GITMO) (2013) Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process. Transfusion 53(10):2340–2352PubMed
35.
go back to reference Zeiser R, Burchert A, Lengerke C, Verbeek M, Maas-Bauer K, Metzelder SK, Spoerl S, Ditschkowski M, Ecsedi M, Sockel K, Ayuk F, Ajib S, de Fontbrune FS, Na IK, Penter L, Holtick U, Wolf D, Schuler E, Meyer E, Apostolova P, Bertz H, Marks R, Lübbert M, Wäsch R, Scheid C, Stölzel F, Ordemann R, Bug G, Kobbe G, Negrin R, Brune M, Spyridonidis A, Schmitt-Gräff A, van der Velden W, Huls G, Mielke S, Grigoleit GU, Kuball J, Flynn R, Ihorst G, du J, Blazar BR, Arnold R, Kröger N, Passweg J, Halter J, Socié G, Beelen D, Peschel C, Neubauer A, Finke J, Duyster J, von Bubnoff N (2015) Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey. Leukemia 29(10):2062–2068CrossRefPubMedPubMedCentral Zeiser R, Burchert A, Lengerke C, Verbeek M, Maas-Bauer K, Metzelder SK, Spoerl S, Ditschkowski M, Ecsedi M, Sockel K, Ayuk F, Ajib S, de Fontbrune FS, Na IK, Penter L, Holtick U, Wolf D, Schuler E, Meyer E, Apostolova P, Bertz H, Marks R, Lübbert M, Wäsch R, Scheid C, Stölzel F, Ordemann R, Bug G, Kobbe G, Negrin R, Brune M, Spyridonidis A, Schmitt-Gräff A, van der Velden W, Huls G, Mielke S, Grigoleit GU, Kuball J, Flynn R, Ihorst G, du J, Blazar BR, Arnold R, Kröger N, Passweg J, Halter J, Socié G, Beelen D, Peschel C, Neubauer A, Finke J, Duyster J, von Bubnoff N (2015) Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey. Leukemia 29(10):2062–2068CrossRefPubMedPubMedCentral
Metadata
Title
Bronchoscopic features, associations, and outcomes of organizing pneumonia following allogeneic hematopoietic stem cell transplantation
Authors
Kyle R. Brownback
John W. Frey
Sunil Abhyankar
Publication date
01-09-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03746-3

Other articles of this Issue 9/2019

Annals of Hematology 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.